Work

Rationale and Design of the Hemodynamic, Echocardiographic and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: A Randomized Controlled Trial in Patients Hospitalized With Heart Failure (HORIZON-HF) Trial

Year: 2008

Type: article

Source: American Journal of Therapeutics

DOI: 10.1097/mjt.0b013e31816d9186

Authors: John E A Blair, Cezar Macarie, Witold Ruzyllo, Antonella Bacchieri, Giovanni Valentini, Maria Bianchetti, Peter S Pang, Matthew E Harinstein, Hani N Sabbah, Gerasimos S Filippatos, Mihai Gheorghiade

Institutions: Northwestern University, Institute of Cardiology, Sigma Tau (Italy), Henry Ford Health, National and Kapodistrian University of Athens

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2043990563

FWCI: 1.697

Cites: 15

Cited by: 18

Related to: 10